Elisabeth Kjellén
61 – 70 of 103
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=""
width=""
height=""
allowtransparency="true"
frameborder="0">
</iframe>
- 2009
-
Mark
Early changes in 2-deoxy-2-[18F]fluoro-D-glucose metabolism in squamous-cell carcinoma during chemotherapy in vivo and in vitro.
- Contribution to journal › Article
-
Mark
Multicentre phase II trial of capecitabine and oxaliplatin in combination with radiotherapy for unresectable colorectal cancer: The CORGI-L study.
- Contribution to journal › Article
-
Mark
No direct effects of erythropoietin beta on a head and neck squamous cell carcinoma cell line which is growth stimulated in vivo.
- Contribution to journal › Article
-
Mark
Epidermal growth factor receptor status and persistent activation of Akt and p44/42 MAPK pathways correlate with the effect of cetuximab in head and neck and colon cancer cell lines.
- Contribution to journal › Article
-
Mark
Regression of cervical spinal cord compression in a patient with chordoma following treatment with cetuximab and gefitinib.
- Contribution to journal › Letter
-
Mark
The effect on the small bowel of 5-FU and oxaliplatin in combination with radiation using a microcolony survival assay.
- Contribution to journal › Article
- 2008
-
Mark
The quality assurance process for the ARTSCAN head and neck study - A practical interactive approach for QA in 3DCRT and IMRT
- Contribution to journal › Article
-
Mark
Chemorefractory rhabdomyosarcoma treated with radiotherapy, bevacizumab, statins and surgery and maintenance with bevacizumab and chemotherapy.
- Contribution to journal › Article
- 2007
-
Mark
What's new in target volume definition for radiologists in ICRU Report 71? How can the ICRU volume definitions be integrated in clinical practice?
- Contribution to journal › Article
-
Mark
NTCP modelling and pulmonary function tests evaluation for the prediction of radiation induced pneumonitis in non-small-cell lung cancer radiotherapy
- Contribution to journal › Article
